• Natasa Teovska Mitrevska Re - Medika General Hospital, Dermatology Department, Skopje, Republic of North Macedonia


Vitiligo, QL, quality of life index, psoriasis, alopecia areata, body surface area measurement index (BSA), DLQI.


Many skin conditions affect patients in a multidimensional way, ranging from emotional to social interaction, symptoms, and functional impairment.

Aim: The aim of the study was to measure the QL of patients with vitiligo, expressed through the Dermatological Quality of Life Index (DLQI), as well as the correlation between, disease activity and demographic characteristics.

Materials and methods: This cross-sectional study was realized in a period of 1 year. Two questionnaires were used in the study: the first questionnaire contains data from the DLQI, which measures the QL. The second contains demographic characteristics of patients (age, gender, place of residence, marital status, education), disease activity, comorbid diseases, and size of BSA. DLQI was used for comparison of patients with newly diagnosed vitiligo and also, a comparison was made in terms of disease spread and stability. Data analysis was performed using the Statistica 7.1 for Windows and SPSS Statistics 23.0.

Results: Among 70 subjects included in the study, the total score for the DLQI ranged from 0 to 28 and the average was 11.70±5.7.  The QL was significantly worse in the studied group of 16-30 years (13.85±5.3) compared to the population of 51-60 and over 60 years (6.75±5.7, and 7.0±2.3) in terms of daily activities and leisure activities and  treatment. As the age of patients with vitiligo advanced, the QL improved. Subjects with higher education had a higher DIQS score (14.41±6.6; p=0.001).


The WHOQOL Group. The World Health Organization Quality of Life Assessment (WHOQOL): development and general psychometric properties. Soc Sci Med 1998; 46(12): 1569-1585. doi: 10.1016/s0277-9536(98)00009-4.

Rosenberg M. Conceiving the Self. New York: Creative Education; 2016.

Taïeb A. The definition and assessment of vitiligo: A consensus report of the Vitiligo European Task Force. Pigment Cell Research 2007; 20(1): 27-35. doi: 10.1111/j.1600-0749.2006.00355.x.

Finlay A, Khan G. Dermatology life quality index [DLQI]: A simple practical measure for routine clinical use. Clin Exp Dermatol 1994; 19(3): 210-216. doi: 10.1111/j.1365-2230.1994.tb01167.x.

Dolatshahi A, Ghazi P, Feizy V, Hemami M. Life quality assessment among patients with vitiligo: Comparison of life quality assessment among patients with vitiligo: Comparison of married and single patients in Iran. Indian J Dermatol Venereol Leprol 2008; 74(6): 700. doi: 10.4103/0378-6323.45141.

Budania A, Parsad D, Kanwar AJ, Dogra S. Comparison between autologous noncultured epidermal cell suspension and suction blister epidermal grafting in stable vitiligo: a randomized study. Br J Dermatol 2012; 167(6): 1295-1301. doi: 10.1111/bjd.12007.

Ongenae K, Dierckxsens L, Brochez L, van Geel N, Naeyaert JM. Quality of life and stig- matization profile in a cohort of vitiligo patients and effect of the use of camouflage. Dermatology 2005; 210(4): 279-285. doi: 10.1159/000084751.

Mechri A, Amri M, Douarika AA, Ali Hichem BH, Zouari B, Zili J. Psychiatric morbidity and quality of life in vitiligo: a case-controlled study. Tunis Med 2006; 84(10): 632-635. PMID: 17193855.

Van Geel N, Ongenae K, Vander Heghen Y, Vervaet C, Naeyaert JM. Subjective and objective evaluation of noncultured epidermal cellular grafting for repigmenting vitiligo. Dermatology 2006; 213(1): 23-29. doi: 10.1159/000092833.

Belhadjali H, Amri M, Mecheri A, Doarika A, Khorchani H, Youssef M, et al. Vit- iligo and quality of life: a case-control study. Ann Dermatol Venereol 2007; 134(3 Pt 1): 233-236. doi: 10.1016/s0151-9638(07)91814-1.

Al Robaee AA. Assessment of quality of life in Saudi patients with vitiligo in a medical school in Qassim province, Saudi Arabia. Saudi Med J 2007; 28(9): 1414-1417. PMID: 17768471.

Kostopoulou P, Jouary T, Quintard B, Ezzedine K, Marques S, Boutchnei S, et al. Objective vs subjective factors in the psychological impact of vitiligo: the experience from a French referral centre. Br J Dermatol 2009; 161(1): 128-133. doi: 10.1111/j.1365-2133.2009.09077.x.

Radtke MA, Schäfer I, Gajur A, Langenbruch A, Augustin M. Willingness-to-pay and qual- ity of life in patients with vitiligo. Br J Dermatol 2009; 161(1): 134-139. doi: 10.1111/j.1365-2133.2009.09091.x.

Mashayekhi V, Javidi Z, Kiafar B, Manteghi AA, Saadatian V, Esmaeili HA, et al. Quality of life in patients with vitiligo: a descriptive study on 83 patients attending a PUVA therapy unit in Imam Reza Hospital, Mashad. Indian J Dermatol Venereol Leprol 2010; 76(5): 592. doi: 10.4103/0378-6323.69097.

Wang KY, Wang KH, Zhang ZP. Health related quality of life and marital quality of vitiligo patients in China. J Eur Acad Dermatol Venereol 2011; 25(4): 429-435. doi: 10.1111/j.1468-3083.2010.03808.x.

Chan MF, Chua TL, Goh BK, Aw CWD, Thng TGS, Lee SM. Investigating factors associated with depression of vitiligo patients in Singapore. J Clin Nurs 2012; 21(11-12): 1614-1621. doi: 10.1111/j.1365-2702.2011.03777.x.

Wong S, Baba R. Quality of life among Malaysian patients with vitiligo. Int J Dermatol 2012; 51(2): 156-161. doi: 10.1111/j.1365-4632.2011.04932.x.

Ingordo V, Cazzaniga S, Gentile C, Iannazzone SS, Cusano F, Naldi L. Dermatology Life Quality Index score in vitiligo patients: a pilot study among young Italian males. G Ital Dermatol Venereol 2012; 147(1): 83-90. PMID: 22370571.

Silverberg JI, Silverberg NB. Association between vitiligo extent and distribution and quality-of-life. JAMA Dermatol 2013; 149(2): 159-164. doi: 10.1001/jamadermatol.2013.927.

Kiprono S, Chaula B, Makwaya C, Naafs B, Masenga J. Quality of life of patients with vit iligo attending the Regional Dermatology Training Center in Northern Tanzania. Int J Dermatol 2013; 52(2): 191-194. doi: 10.1111/j.1365-4632.2012.05600.x.

Karelson M, Silm H, Kingo K. Quality of life and emotional state in vitiligo in an Estonian sample: comparison with psoriasis and healthy controls. Acta Derm Venereol 2013; 93(4): 446-450. doi: 10.2340/00015555-1520.

Bishnoi A, Parsad D. Clinical and Molecular Aspects of Vitiligo Treatments. Int J Mol Sci 2018; 19(5): 1509. doi: 10.3390/ijms19051509.

Ongenae K, Beelaert L, van Geel N, Naeyaert J. Psychosocial effects of vitiligo. J Eur Acad Dermatol Venereol 2006; 20(1): 1-8. doi: 10.1111/j.1468-3083.2005.01369.x.

Speeckaert R, Van Geel N. Distribution patterns in generalized vitiligo. Journal of the European Academy of Dermatology and Venereology 2014; 28(6): 755-762. doi: 10.1111/jdv.12171.

Sehgal V, Govind S. Sehgal VN, Srivastava G. Vitiligo: compendium of clinic epidemiological features. Indian J Dermatol Venereol Leprol 2007; 73(3): 149-156.

Liu JW, Tan Y, Chen T, Liu W, Qian YT, Ma DL. Post Traumatic Stress in Vitiligo Patients: A Neglected but Real-Existing Psychological Impairment. Clin Cosmet Investig Dermatol 2022; 15: 373-382. doi: 10.2147/CCID.S350000.

Al-Shammari SA, Alotaibi HM, Assiri MA, Altokhais MI, Alotaibi MS, Alkhowailed MS. Quality of life in vitiligo patients in central Saudi Arabia. Saudi Med J 2021; 42(6): 682-687. doi: 10.15537/smj.2021.42.6.20200833.

Amer AA, Gao XH. Quality of life in patients with vitiligo: an analysis of the dermatology life quality index outcome over the past two decades. Int J Dermatol 2016; 55(6): 608-614. doi: 10.1111/ijd.13198.

Picardo M, Huggins RH, Jones H, Marino R, Ogunsola M, Seneschal J. The humanistic burden of vitiligo: a systematic literature review of quality-of-life outcomes. J Eur Acad Dermatol Venereol 2022; 36(9): 1507-1523. doi: 10.1111/jdv.18129.

Bibeau K, Ezzedine K, Harris JE, van Geel N, Grimes P, Parsad D, et al. Mental Health and Psychosocial Quality-of-Life Burden Among Patients with Vitiligo: Findings from the Global VALIANT Study. JAMA Dermatol 2023; 159(10): 1124-1128. doi: 10.1001/jamadermatol.2023.2787.






Original Articles